Decrease of serum chemerin concentration in patients with end stage renal disease after successful kidney transplantation

Regulatory Peptides

Volumn 173, Issue 1-3, 2012, Pages 55-59

  Rutkowski, Przemyslaw ^a   Sledzinski, Tomasz ^a   Zielinska, Hanna ^a   Lizakowski, Slawomir ^a   Goyke, Elzbieta ^a   Szrok Wojtkiewicz, Sylwia ^a   Swierczynski, Julian ^a   Rutkowski, Bolesław ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Chemerin; Kidney transplantation; Renal function

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CALCIUM; CHEMERIN; CREATININE; HEMOGLOBIN; PHOSPHATE; UNCLASSIFIED DRUG; UREA;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINES; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; YOUNG ADULT;

EID: 83255187175     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.09.005     Document Type: Article

References (38)

1. Zabel B.A., Silverio A.M., Butcher E.C. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J Immunol 2005, 174:244-251.
2. Wittamer V., Franssen J.D., Vulcano M., Mirjolet J.F., Le P.E., Migeotte I., Brezillon S., Tyldesley R., Blanpain C., Detheux M., Mantovani A., Sozzani S., Vassart G., Parmentier M., Communi D. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 2003, 198:977-985.
3. Bozaoglu K., Bolton K., McMillan J., Zimmet P., Jowett J., Collier G., Walder K., Segal D. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007, 148:4687-4694.
4. Goralski K.B., McCarthy T.C., Hanniman E.A., Zabel B.A., Butcher E.C., Parlee S.D., Muruganandan S., Sinal C.J. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007, 282:28175-28188.
5. Albanesi C., Scarponi C., Pallotta S., Daniele R., Bosisio D., Madonna S., Fortugno P., Gonzalvo-Feo S., Franssen J.D., Parmentier M., De P.O., Girolomoni G., Sozzani S. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med 2009, 206:249-258.
6. Du X.Y., Zabel B.A., Myles T., Allen S.J., Handel T.M., Lee P.P., Butcher E.C., Leung L.L. Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets. J Biol Chem 2009, 284:751-758.
7. Du X.Y., Leung L.L. Proteolytic regulatory mechanism of chemerin bioactivity. Acta Biochim. Biophys. Sin. (Shanghai) 2009, 41:973-979.
8. Ernst M.C., Sinal C.J. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 2011, 21:660-667.
9. John H., Hierer J., Haas O., Forssmann W.G. Quantification of angiotensin-converting-enzyme-mediated degradation of human chemerin 145-154 in plasma by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. Anal Biochem 2007, 362:117-125.
10. Zabel B.A., Ohyama T., Zuniga L., Kim J.Y., Johnston B., Allen S.J., Guido D.G., Handel T.M., Butcher E.C. Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-beta and TLR ligands. Exp Hematol 2006, 34:1106-1114.
11. Kaur J., Adya R., Tan B.K., Chen J., Randeva H.S. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem Biophys Res Commun 2010, 391:1762-1768.
12. Barnea G., Strapps W., Herrada G., Berman Y., Ong J., Kloss B., Axel R., Lee K.J. The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci USA 2008, 105:64-69.
13. Parolini S., Santoro A., Marcenaro E., Luini W., Massardi L., Facchetti F., Communi D., Parmentier M., Majorana A., Sironi M., Tabellini G., Moretta A., Sozzani S. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007, 109:3625-3632.
14. Lehrke M., Becker A., Greif M., Stark R., Laubender R.P. Z.F. von, C. Lebherz, J. Tittus, M. Reiser, C. Becker, B. Goke, A.W. Leber, K.G. Parhofer, U.C. Broedl, Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 2009, 161:339-344.
15. Weigert J., Neumeier M., Wanninger J., Filarsky M., Bauer S., Wiest R., Farkas S., Scherer M.N., Schaffler A., Aslanidis C., Scholmerich J., Buechler C. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 2010, 72:342-348.
16. Skrzeczynska-Moncznik J., Wawro K., Stefanska A., Oleszycka E., Kulig P., Zabel B.A., Sulkowski M., Kapinska-Mrowiecka M., Czubak-Macugowska M., Butcher E.C., Cichy J. Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin. Biochem Biophys Res Commun 2009, 380:323-327.
17. Graham K.L., Zabel B.A., Loghavi S., Zuniga L.A., Ho P.P., Sobel R.A., Butcher E.C. Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease. J Immunol 2009, 183:6717-6723.
18. Pasceri V., Yeh E.T. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999, 100:2124-2126.
19. Fernandez-Ranvier G.G., Weng J., Yeh R.F., Khanafshar E., Suh I., Barker C., Duh Q.Y., Clark O.H., Kebebew E. Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling. Arch Surg 2008, 143:841-846.
20. Mohr S., Bottin M.C., Lannes B., Neuville A., Bellocq J.P., Keith G., Rihn B.H. Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells. Biochimie 2004, 86:13-19.
21. Zheng Y., Luo S., Wang G., Peng Z., Zeng W., Tan S., Xi Y., Fan J. Downregulation of tazarotene induced gene-2 (TIG2) in skin squamous cell carcinoma. Eur J Dermatol 2008, 18:638-641.
22. Stepan H., Philipp A., Roth I., Kralisch S., Jank A., Schaarschmidt W., Lossner U., Kratzsch J., Bluher M., Stumvoll M., Fasshauer M. Serum levels of the adipokine chemerin are increased in preeclampsia during and 6months after pregnancy. Regul Pept 2011, 168:69-72.
23. Weigert J., Obermeier F., Neumeier M., Wanninger J., Filarsky M., Bauer S., Aslanidis C., Rogler G., Ott C., Schaffler A., Scholmerich J., Buechler C. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Inflamm Bowel Dis 2010, 16:630-637.
24. Kukla M., Zwirska-Korczala K., Hartleb M., Waluga M., Chwist A., Kajor M., Ciupinska-Kajor M., Berdowska A., Wozniak-Grygiel E., Buldak R. Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010, 45:235-242.
25. Tan B.K., Chen J., Farhatullah S., Adya R., Kaur J., Heutling D., Lewandowski K.C., O'Hare J.P., Lehnert H., Randeva H.S. Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 2009, 58:1971-1977.
26. Adrych K., Stojek M., Smoczynski M., Sledzinski T., Szrok-Wojtkiewicz S., Swierczynski J. Increased serum chemerin concentration in patients with chronic pancreatitis. Dig Liver Dis 2011, 10.1016/j.dld.2011.06.020.
27. Hu W., Feng P. Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients. Diabetes Res Clin Pract 2011, 91:159-163.
28. Pfau D., Bachmann A., Lossner U., Kratzsch J., Bluher M., Stumvoll M., Fasshauer M. Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care 2010, 33:171-173.
29. Yamamoto T., Qureshi A.R., Anderstam B., Heimburger O., Barany P., Lindholm B., Stenvinkel P., Axelsson J. Clinical importance of an elevated circulating chemerin level in incident dialysis patients. Nephrol Dial Transplant 2010, 25:4017-4023.
30. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., Kusek J.W., Eggers P., Van L.F., Greene T., Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
31. Stejskal D., Karpisek M., Hanulova Z., Svestak M. Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-a pilot study. Biomed. Pap. Med. Fac. Univ Palacky. Olomouc. Czech. Repub. 2008, 152:217-221.
32. Merabet E., Dagogo-Jack S., Coyne D.W., Klein S., Santiago J.V., Hmiel S.P., Landt M. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 1997, 82:847-850.
33. Zoccali C., Mallamaci F., Tripepi G., Benedetto F.A., Cutrupi S., Parlongo S., Malatino L.S., Bonanno G., Seminara G., Rapisarda F., Fatuzzo P., Buemi M., Nicocia G., Tanaka S., Ouchi N., Kihara S., Funahashi T., Matsuzawa Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002, 13:134-141.
34. Ziegelmeier M., Bachmann A., Seeger J., Lossner U., Kratzsch J., Bluher M., Stumvoll M., Fasshauer M. Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care 2007, 30:2588-2592.
35. Roh S.G., Song S.H., Choi K.C., Katoh K., Wittamer V., Parmentier M., Sasaki S. Chemerin-a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 2007, 362:1013-1018.
36. Takahashi M., Takahashi Y., Takahashi K., Zolotaryov F.N., Hong K.S., Kitazawa R., Iida K., Okimura Y., Kaji H., Kitazawa S., Kasuga M., Chihara K. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett 2008, 582:573-578.
37. Zabel B.A., Allen S.J., Kulig P., Allen J.A., Cichy J., Handel T.M., Butcher E.C. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem 2005, 280:34661-34666.
38. Stenvinkel P. Inflammation in end-stage renal disease-a fire that burns within. Contrib Nephrol 2005, 149:185-199.